A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours-Reference-Cited by-同舟云学术

A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours

Published:2020-09 Issue: Volume:325 Page:191-197
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Atrafi Florence,Dumez Herlinde,Mathijssen Ron H.J.,Menke van der Houven van Oordt Catharine W,Rijcken Cristianne J.F.,Hanssen Rob,Eskens Ferry A.L.M.,Schöffski Patrick

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference25 articles.

1. Clinical pharmacokinetics of docetaxel;Clarke;Clin. Pharmacokinet.,1999

2. Docetaxel administration schedule: from fever to tears? A review of randomised studies;Engels;Eur. J. Cancer,2005

3. Mode of action of docetaxel - a basis for combination with novel anticancer agents;Herbst;Cancer Treat. Rev.,2003

4. Inter-patient variability in docetaxel pharmacokinetics: a review;Nieuweboer;Cancer Treat. Rev.,2015

5. Nanomedicine therapeutic approaches to overcome cancer drug resistance;Markman;Adv. Drug Deliv. Rev.,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials;Pharmaceutics;2024-08-06

2. Concepts and Approaches to Reduce or Avoid Protein Corona Formation on Nanoparticles: Challenges and Opportunities;Advanced Science;2024-07-08

3. Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer;Current Drug Delivery;2024-06

4. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery;Journal of Drug Targeting;2024-05-09

5. Hydrogel nanoparticles as new drug delivery system for CNS disorders;ChemistrySelect;2024-02-21